Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 1
2006 1
2007 2
2009 1
2014 2
2015 2
2016 2
2018 2
2019 3
2020 1
2021 3
2022 7
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.
Mao Y, Ma S, Liu C, Liu X, Su M, Li D, Li Y, Chen G, Chen J, Chen J, Zhao J, Guo X, Tang J, Zhuge Y, Xie Q, Xie W, Lai R, Cai D, Cai Q, Zhi Y, Li X; Technology Committee on DILI Prevention, Management, Chinese Medical Biotechnology Association; Study Group on Drug-Induced Liver Disease, Chinese Society of Hepatology, Chinese Medical Association. Mao Y, et al. Among authors: cai d. Hepatol Int. 2024 Apr;18(2):384-419. doi: 10.1007/s12072-023-10633-7. Epub 2024 Feb 24. Hepatol Int. 2024. PMID: 38402364
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study.
Wong YJ, Tran S, Huang CF, Hsu YC, Preda C, Toyoda H, Liu J, Jun DW, Landis C, Huang DQ, Gila A, Negoita L, Yasuda S, Tseng CH, Tsai PC, Uojima H, Nozaki A, Chuma M, Atsukawa M, Ishigami M, Itokawa N, Iio E, Lam CP, Watanabe T, Asai A, Yokohama K, Abe H, Enomoto M, Kawada N, Tamori A, Lee DH, Jun MJ, Do S, Vo DKH, Liu L, Li J, Ji F, Wang W, Li Y, Wang X, Guo F, Xu Q, Jing L, Ye Q, Pan H, Zhang J, Wen X, Wang Q, Ren H, Cai D, Shang J, Liu J, Lu C, Zang W, Li J, Niu J, Zhang M, Wu C, Huang R, Maeda M, Nakanishi A, Yeh ML, Chuang WL, Huang JF, Dai C, Ishikawa T, Takaguchi K, Senoh T, Trinh HN, Takahashi H, Eguchi Y, Quek SXZ, Haga H, Ogawa E, Wong G, Buti M, Fukunishi S, Ueno Y, Yuen MF, Tanaka Y, Lim SG, Cheung R, Yu ML, Nguyen MH. Wong YJ, et al. Among authors: cai d. Hepatol Int. 2023 Oct;17(5):1150-1161. doi: 10.1007/s12072-023-10547-4. Epub 2023 Jun 5. Hepatol Int. 2023. PMID: 37273170
Humoral responses after primary and booster SARS-CoV-2 inactivated vaccination in patients with chronic hepatitis B virus infection: A longitudinal observational study.
Chen Z, Huang T, He T, Zha G, Zhu Q, Zhang G, Xiang D, Chen M, Li H, Ling N, Lan Y, Shi X, Zhang D, Xu P, Pan Q, Song R, Cao J, Zhang Y, Xiang H, Feng Y, Yang Z, Zhang B, Shen W, Cai D, Peng M, Hu P, Ren H. Chen Z, et al. Among authors: cai d. J Med Virol. 2023 Apr;95(4):e28695. doi: 10.1002/jmv.28695. J Med Virol. 2023. PMID: 36946505
Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection.
He T, Zhou Y, Xu P, Ling N, Chen M, Huang T, Zhang B, Yang Z, Ao L, Li H, Chen Z, Zhang D, Shi X, Lei Y, Wang Z, Zeng W, Hu P, Lan Y, Zhou Z, Kang J, Huang Y, Shi T, Pan Q, Zhu Q, Ran X, Zhang Y, Song R, Xiang D, Xiao S, Zhang G, Shen W, Peng M, Cai D, Ren H. He T, et al. Among authors: cai d. Liver Int. 2022 Jun;42(6):1287-1296. doi: 10.1111/liv.15173. Epub 2022 Feb 28. Liver Int. 2022. PMID: 35107848
Weakened humoral immune responses of inactivated SARS-CoV-2 vaccines in patients with solid tumors.
Chen Z, Zhu P, Liu Z, Zhu B, Yin G, Ming J, Song R, Pan Q, Li T, Jiang X, Wang B, Liu S, Cai H, Wang J, Han Y, Lin Z, Hong Y, Chen M, Peng M, Hu L, Cai D, Ren H. Chen Z, et al. Among authors: cai d. Cancer Commun (Lond). 2023 Feb;43(2):280-284. doi: 10.1002/cac2.12368. Epub 2022 Nov 4. Cancer Commun (Lond). 2023. PMID: 36330800 Free PMC article. No abstract available.
46 results